AMLEXIN
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 06 Feb 2025)
What this means for you
Registered since 23 Oct 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 Oct 2028: the §8 & §9 renewal).
Record
- Serial number
- 87513541
- Registration number
- 5588771
- Mark type
- Word mark
- Filed
- 30 Jun 2017
- Published for opposition
- 08 May 2018
- Registered
- 23 Oct 2018
- Next maintenance filing
- §8 & §9 renewal, due by 23 Oct 2028 (grace period to 23 Apr 2029)
- Attorney of record
- Dr. Sandra P. Thompson
Goods and services
- Class 005 — Pharmaceuticals: Nutraceuticals for joint flexibility preservation, joint cartilage protection, cartilage degradation protection, and cartilage protection, and anti-oxidant nutraceutical preparations for use as nutritional supplements
Owner
- Unigen, Inc., Tacoma, WA, US
- Unigen, Inc., Seattle, WA, US
- Unigen, Inc., Seattle, WA, US
Board proceedings on this mark
- Extension of Time to Oppose No. 87513541 — Sanofi v. Unigen, Inc., filed 30 May 2018 (Terminated)
Prosecution history
- 06 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Feb 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Sept 2024 — TEAS SECTION 8 & 15 RECEIVED
- 23 Oct 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Oct 2018 — REGISTERED-PRINCIPAL REGISTER
- 16 Sept 2018 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 19 Aug 2018 — POST PUBLICATION AMENDMENT - ENTERED
- 16 Aug 2018 — ASSIGNED TO PETITION STAFF
- 30 Jul 2018 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 30 May 2018 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 08 May 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 May 2018 — PUBLISHED FOR OPPOSITION
- 18 Apr 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Apr 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER